跳至主要内容
临床试验/JPRN-UMIN000012126
JPRN-UMIN000012126已完成未知

Study of intravitreal aflibercept for exudative age-related macular degeneration - Intravitreal aflibercept for AMD

Department of Ophthalmology, Jikei University School of Medicine0 个研究点目标入组 30 人开始时间: 2013年10月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Greatest Linear Dimension (GLD) of the total lesion area <12 Macular Photocoagulation Study Disc Areas 2) Presence of subretinal hemorrhage, scar or macular fibrosis (>50% lesion area) 3) Prior treatment with anti-VEGF drug, photodynamic therapy 4) Prior treatment with dexamethasone (<6 months) or triamcinolone (<30 days), intraocular surgery (<3 months) 5) Active intraocular inflammation 6) Hypersensitivity or allergy to fluorescein or indocyanine green, clinically significant drug allergy or known hypersensitivity to therapeutic or diagnostic protein products 7) Patient who the doctor in charge judges are ineligible for the study

研究者

发起方
Department of Ophthalmology, Jikei University School of Medicine

相似试验